Overall survival of relapsed and refractory multiple myeloma patients after adjusting for crossover in the MM-003 trial for pomalidomide plus low-dose dexamethasone

DSpace Repository

Overall survival of relapsed and refractory multiple myeloma patients after adjusting for crossover in the MM-003 trial for pomalidomide plus low-dose dexamethasone

Author: Morgan, Gareth; Palumbo, Antonio; Dhanasiri, Sujith; Lee, Dawn; Weisel, Katja; Facon, Thierry; Delforge, Michel; Oriol, Albert; Zaki, Mohamed; Yu, Xin; Sternas, Lars; Jacques, Christian; Akehurst, Ron; Offner, Fritz; Dimopoulos, Meletios A.
Tübinger Autor(en):
Weisel, Katja
Published in: British Journal of Haematology (2015), Bd. 168, H. 6, S. 820-823
Verlagsangabe: Wiley - Blackwell
Language: English
Full text: http://dx.doi.org/10.1111/bjh.13227
ISSN: 0007-1048
DDC Classifikation: 610 - Medicine and health
Dokumentart: Artikel
Show full item record

This item appears in the following Collection(s)